Biomarker ID | 1557 |
PMID | 9815775 |
Year | 1997 |
Biomarker | Chondroitin Sulfate |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated in Prostate Cancer |
Odds Ratio/Hazard Ratio/Relative Risk | RR: 1.17 (95% CI: 1.08-1.27) |
Effect on Pathways | Pathways include: Chondroitin sulfate/dermatan sulfate metabolism; Metabolism; Glycosaminoglycan metabolism |
Experiment | Progression Vs No Progression |
Type of Biomarker | Prognostic |
Cohort | 43 men with prostate cancer were chosen for this study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.0001 |
Method Used | Immunohistochemistry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |